Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients With COPD
This study is enrolling participants by invitation only.
Sponsor:
Hospital Hietzing
Information provided by:
Hospital Hietzing
ClinicalTrials.gov Identifier:
NCT00469313
First received: May 2, 2007
Last updated: May 21, 2008
Last verified: May 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hypothesis:benefits of inspiratory muscle strenght training with Respifit S decreases symptoms, disability or handicap of patients affected by COPD. The inspiratory fraction (inspiratory capacity IC/ total lung capacity TLC)may be functionally more representative than other traditional indices.
| Condition |
|---|
|
COPD |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients |
Further study details as provided by Hospital Hietzing:
Eligibility| Ages Eligible for Study: | 40 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- COPD GOLD II-III (FEV1<80 and >30%)
Exclusion Criteria:
- Pregnancy
- Lung cancer
- Diabetes mellitus
- Primary exacerbation of COPD
Contacts and Locations
More Information
No publications provided by Hospital Hietzing
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00469313 History of Changes |
| Other Study ID Numbers: | L1234 |
| Study First Received: | May 2, 2007 |
| Last Updated: | May 21, 2008 |
| Health Authority: | Austria: Federal Institute for Drugs and Medical Devices |
Keywords provided by Hospital Hietzing:
|
copd inspiratory muscle training IF |
Additional relevant MeSH terms:
|
Respiratory Aspiration Pulmonary Disease, Chronic Obstructive Respiration Disorders Respiratory Tract Diseases |
Signs and Symptoms, Respiratory Signs and Symptoms Lung Diseases, Obstructive Lung Diseases |
ClinicalTrials.gov processed this record on May 22, 2013